AIIMS Delhi is developing a low-cost antibody-based CAR-T cell therapy for multiple myeloma, a blood cancer. Targeting B-cell ...

Bioprocessing technology has a role to play in helping developers exert greater control over production processes.

For CRISPR Therapeutics specifically, that financial flexibility is not necessarily needed even if it's a plus. As of the most recent quarter, Q3, it reported having around $1.9 billion in cash, ...

As the founder and CEO of Immunocine Cancer Center, based in Cancún, Mexico, he has transformed his vision into reality with ...

A lengthy treatment process, coupled with weighty risks for recipients to consider, has resulted in plodding adoption of ...

Roswell Park Comprehensive Cancer Center next month will open a $98 million facility dedicated to developing new cancer ...

The new, long-term lease includes an immediate $12 million capital investment in facility upgrades, equipment and business ...

Findings reveal that metabolic enzymes ACSS2 and ACLY regulate T cell exhaustion, linking nutrient metabolism to epigenetic ...

The most-read gene therapy articles included topics on FDA approvals, chimeric antigen receptor T-cell therapies, the ...

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science ...

Doctors at AIIMS, Delhi are in the process of developing a low-cost antibody-based adaptive cellular therapy for treatment of ...

According to latest data from National cancer registry, the estimated number of incident cases of cancer in India in 2022 was ...